ArticleAmerican journal of cancer research2025

Enhanced glycolysis induced by activation of AKT/NF-κB signaling pathway contributes to doxorubicin resistance in DLBCL.

Yong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.